Growth hormone and colorectal carcinoma: Localization of receptors

In Vivo

Volumn 14, Issue 1, 2000, Pages 41-49

  Lincoln, David T ^c   Kaiser, Hans E ^a   Raju, Gana P ^d   Waters, Michael J ^b  

^a Intl Soc Stud Compar Oncol   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c KUWAIT UNIVERSITY   (Kuwait)

^d NONE

Author keywords

Colorectal carcinoma; Growth hormone; Growth hormone receptor; Immunohistochemistry

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CACHEXIA; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CRYPT CELL; FEMALE; HORMONE BINDING; HUMAN; IMMUNOREACTIVITY; MALE;

EID: 0034025706     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Leblong CP, Carriere R: The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa ofthe rat. Endocrinol 56: 261-266, 1955.
2. Scow RO, Hagan SN: Effect of testerone propionate and growth hormone on growth and chemical composition of muscle and other tissues in hypophysectomized rats. Endocrinol 77: 852-858, 1965.
3. Cooke PS, Yonemura CU, Russell SM, Nicoll CS: Growth and differentiation of foetal rat intestine transplants: dependence on insulin and growth hormone. Biol Neonate 49: 211-218, 1986.
4. Chipman JJ, Zerwekh J, Nicar M, Marks J, Pak CYC: Effect of growth hormone administration: Reciprocal changes in serum 1α25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab 51: 321-328, 1980.
5. Bruns MEH, Volmer SS, Bruns DE, Overpeck JG: Human growth hormone increases intestinal vitamin D dependent calcium binding protein in hypophysectomized rats. Endocrinol 113: 1387-1394, 1983.
6. Torosian MH, Donoway RB: Growth hormone inhibits tumour metastasis. Cancer 67: 2280-2283, 1991.
7. Wilmore WW, Moylan JA, Bristow BF, Mason AD, Pruitt BA: Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 138: 875-879, 1974.
8. Manson JM, Wilmore DW: Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 100: 188-197, 1986.
9. Ward HC, Halliday D, Sim AJW: Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 206: 56-61, 1987.
10. Daughaday WH: A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity. Perspect Biol Med 32: 194, 1989.
11. Hansson HA, Nilsson A, Isgaard J, Billig H, Isaksson OGP, Skottner A, Andersson IK, Rozell B: Immunohistochemical localization of insulin like growth factor-I in the adult rat. Histochemistry 89: 403-410, 1988.
12. Hynes MA, Van Wyk J, Brooks PJ, D'Ercole AJ, Jansen M, Lund PK: Growth hormone dependence of somatomedin C/insulin like growth factor-1 and insulin like growth factor-2 messenger ribonucleic acids. Mol Endocrinol 1: 233-242, 1987.
13. Lincoln DT, El-Hifnawi E, Sinowatz F, Waters, M: Immunohistochemical localization of growth hormone receptor binding protein in the mammalian cerebellum. Annals of Anatomy 176: 419-427, 1994.
14. Lincoln DT, Sinowatz F, El-Hifnawi E, Hughes RL, Waters MJ: Evidence of a direct role for growth hormone in mammary gland proliferation and lactation. Anat Histol Embryol 24: 107-115, 1995.
15. Lincoln DT, Sinowatz F, Gabius HJ, Gabius S, Temmim-Baker L, Baker H, Mathew CT: Subpopulations of stromal cells from long-term human bone marrow cultures: ontogeny of progenitor cells and expression of growth hormone receptors. Anat Hist Embryol 26: 11-28, 1997.
16. Lincoln DT, Sinowatz F, Temmim-Baker L, Baker H, Kolle S, Waters MJ: Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol 109: 141-159, 1998.
17. Lincoln DT, Snyder JR, Sinowatz F, Waters MJ: Adaptation of growth hormone receptor expression to tumour growth. In: Adaptation Biology and Medicine, Vol. 2, Molecular Basis. (K B Pandolf, N Takeda and P K Singal eds.), New Delhi, London, Narosa Publishing House, 1999, pp 119-138.
18. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GJ, Shows TB: Enhanced levels of insulin-like growth factor Messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 46: 6169-6173, 1986.
19. Ituarte EA, Petrini J, Hersman JM: Acromegaly and colon cancer. Ann Intern Med 101: 627-628, 1984.
20. Ritter MM, Richter WO, Schwandt P: Acromegaly and colon cancer. Ann Inter Med 106: 636-637, 1987.
21. Ziel FH, Peters AL: Acromegaly and gastrointestinal adenocarcinomas. Ann Intern Med 108: 514-515, 1988.
22. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brulmer JF, Mellinger RC: Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol 32: 65-71, 1990.
23. Barnard R, Bundesen PG, Rylatt DB, Waters MJ: Monoclonal antibodies to the rabbit liver growth hormone receptor: production and characterization. Endocrinol 115: 1805-1813, 1984.
24. Werther GA, Haynes KM, Barnard R, Waters MJ: Visual demonstration of GH receptors on human growth plate chondrocytes. J Clin Endo Metab 70: 1725-1731, 1990.
25. Werther GA, Haynes K, Waters MJ: Growth hormone receptors are expressed on human fetal mesenchymal tissues - Identification of messenger ribonucleic acid and GH-binding protein. J Clin Endocrinol Metab 76: 1638-1646, 1993.
26. Mertani HC, Morel G: In situ gene expression of growth hormone (GH) receptor and GH binding protein in adult male rat tissues. Mol Cell Endocrinol 109: 47-61, 1995.
27. Barnard R, Waters MJ: Evidence for differential binding of growth hormones to membrane and cytosolic GH binding proteins of rabbit liver. J Receptor Res 6: 209-215, 1986.
28. Barnard R, Quirk P, Waters MJ: Characterization of the growth hormone binding protein of human serum using a panel of monoclonal antibodies. J Endocrinol 123: 327-332, 1989.
29. Amit T, Hochberg Z, Waters MJ, Barkey RJ: GH and prolactin binding proteins in mammalian serum. Endocrinol 131: 1793-1803, 1992.
30. Lincoln DT, Sinowatz F, Kolle S, Takahashi H, Parsons P, Waters MJ: Up-regulation of growth hormone receptor immunoreactivity in human melanoma. Anticancer Res 19: 1919-1932, 1999.
31. Lu SH, Hsieh LL, Luo FC, Weinstein IB: Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 42: 502-505, 1988.
32. Minuto F, Del Monte P, Barreca A, Fortini P, Cariola G, Catrambone G, Giordano G: Evidence for an increased somatomedin c/insulin-like growth factor 1 content in primary human lung tumours. Cancer Res 46: 985-988, 1986.
33. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD: Histopathology associated with elevated levels of growth hormone and insulin-like growth factor 1 in transgenic mice. Endocrinol 124: 40-48, 1989.
34. Doglio AJ, Dani C, Fredrikson G: Acute regulation of IGF-I gene expression by growth hormone during adipose cell differentiation. EMBO J 6: 4011-4016, 1987.
35. Andrews GS: Growth hormone and malignancy. J Clin Pathol 36: 935-937, 1983.
36. Adamson U, Brostrom LA, Efendic S: Glucose tolerance, growth hormone and somatomedin levels in osteosarcoma patients. Acta Endocrinol (Copenh.) 94: 517-522, 1980.
37. Carter AC, Lefkon BW, Farlin M: Metabolic parameters in women with metastatic breast cancer. J Clin Endocrinol Metab 40: 260-264, 1975.
38. Murphy LJ, Bell GI, Friesen HG: Growth hormone stimulates sequential induction of c- myc and insulin-like growth factor expression in vivo. Endocrinol 120: 1806-1812, 1987.
39. Goodman MA, McMaster JH, Dreash L: Metabolic and endocrine alterations in osteosarcoma patients. Cancer 42: 603-610, 1978.
40. Bengtsson BA, Eden S, Emest I, Oden A, Sjogren B: Epidemiology and long-term survival in acromegaly. Acta Med Scand 223: 327-335, 1988.
41. Naharro JDN: Acromegaly. Clin Endocrinol 26: 481-512, 1987.
42. Klein I, Parveen G, Gavaler JS, Vanthiel DH: Colonic polyps in patients with acromegaly. Ann Intern Med 97: 27-30, 1982.
43. Pines A, Rozen P, Ron E, Gilat T: Gastrointestinal tumours in acromegalic patients. Am J Gastrenterol 80: 266-269, 1985.
44. Ron E, Gridly G, Hrubec Z, Page, W, Arora S, Fraumeni JF: Acromegaly and gastrointestinal cancer. Cancer 68: 1673-1677, 1991.
45. Gordon D, Hill F, Ezri C: Acromegaly: A review of 100 cases. Can Med Assoc J 87: 1106-1109, 1962.
46. Ratner RE, Hare JW: Association of acromegaly and chondrosarcoma. South Med J 76: 1181-1182, 1983.
47. Haegg E, Asplund K, Holm J: Acromegaly and multiple myeloma. Ann Intern Med 109: 437-438, 1988.
48. Barzilay J, Heatley J, cushing GW: Benign and malignant tumours in patients with acromegaly. Arch Intern Med 151: 1629-1633, 1991.
49. Cats A, Dullaart RP, Kleibueker JH, Kuipers F, Sluiter WJ, Hardonk MJ, de Fries EG: Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56: 523-526, 1996.
50. Cascinu S, Del Ferro E, Grainti C, Ligi M, Ghiselli R, Foglietti G, Saba V, Lungarotti F, Catalano G: Inhibition of tumour cell kinetics and serum insulin-like growth factor I levels by octreotide in colorectal cancer patients. Gastroenterology 113: 767-772, 1997.
51. Binnerts A, Uitterlinden P, Hofland LJ, Van Koetsveld P, Lamberts SWJ: The in vitro and in vivo effects of human growth hormone administration on tumour growth of rats bearing a transplantable rat pituitary tumour. Eur J Cancer 26: 269-276, 1990.
52. Torosian MH, Mullen JL, Miller EE, Zinnser KR, Buzby GP: Reduction of methotrexate toxicity with improved nutritional status in tumour bearing animals. Cancer 61: 1731-1735, 1988.
53. Rudman D, Feller AG, Nagraj HS: Effects of human growth hormone in men over 60 years old. New Engl J Med 323: 1-6, 1990.
54. Suchner U, Rothkopf MM, Stanislaus G, Elwyn DH, Kvetan V, Askanazi J: Growth hormone and pulmonary disease: metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 150: 1225-1230, 1990.
55. Underwood E: Report on the conference on uses and possible abuses of biosynthetic human growth hormone. New Engl J Med 311: 606-608, 1984.
56. Fisher DA, Job JC, Preece M, Underwood E: Leukaemia in patients treated with growth hormone. Lancet 1: 1159-1160, 1988.
57. Stahnke N, Zeisel HJ: Growth hormone therapy and leukaemia. Eur J Pediatr 148: 591-596, 1989.
58. Van Vliet G, Styne DM, Kaplan SI, Grumbach MM: Growth hormone treatment for short stature. New J Med 309: 1016-1022, 1983.
59. Preece MA: Biosynthetic growth hormone: whom to treat? BMJ 293: 1185-1186, 1986.
60. Rosenfeld RG, Hintz RL, Jobanson AJ: Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial. J Pediatr 109: 936-943, 1986.